Given these premises, further investigations will be essential to identify possible phenotype modifiers and to elucidate the effect of PRPH2 variants on protein structure and function, as well as on the onset and progression of IRDs. This evidence concerns the gene PRPH2 and respiratory distress syndrome in premature infants.